Familial adult myoclonic epilepsy type 1 SAMD12 TTTCA repeat expansion arose 17,000 years ago and is present in Sri Lankan and Indian families.


Journal

European journal of human genetics : EJHG
ISSN: 1476-5438
Titre abrégé: Eur J Hum Genet
Pays: England
ID NLM: 9302235

Informations de publication

Date de publication:
07 2020
Historique:
received: 29 08 2019
accepted: 03 03 2020
revised: 05 02 2020
pubmed: 24 3 2020
medline: 28 5 2021
entrez: 24 3 2020
Statut: ppublish

Résumé

Familial adult myoclonic epilepsy 1 (FAME1), first recognised in Japanese families, was recently shown to be caused by a TTTCA repeat insertion in intron 4 of SAMD12 on chromosome 8. We performed whole genome sequencing on two families with FAME, one of Sri Lankan origin and the other of Indian origin, and identified a TTTCA repeat insertion in SAMD12 in both families. Haplotype analysis revealed that both families shared the same core ancestral haplotype reported in Japanese and Chinese families with FAME1. Mutation dating, based on the length of shared haplotypes, estimated the age of the ancestral haplotype to be ~670 generations, or 17,000 years old. Our data extend the geographic range of this repeat expansion to Southern Asia and potentially implicate an even broader regional distribution given the age of the variant. This finding suggests patients of Asian ancestry with suspected FAME should be screened for the SAMD12 TTTCA expansion.

Identifiants

pubmed: 32203200
doi: 10.1038/s41431-020-0606-z
pii: 10.1038/s41431-020-0606-z
pmc: PMC7316749
doi:

Substances chimiques

Nerve Tissue Proteins 0
SAMD12 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

973-978

Subventions

Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : GNT1102971
Pays : International
Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : 1155224
Pays : International
Organisme : Department of Health | National Health and Medical Research Council (NHMRC)
ID : 1091593
Pays : International

Références

van den Ende T, Sharifi S, van der Salm SMA, van Rootselaar AF. Familial cortical myoclonic tremor and epilepsy, an enigmatic disorder: from phenotypes to pathophysiology and genetics. a systematic review. Tremor Other Hyperkinet Mov. 2018;8:503.
Mikami M, Yasuda T, Terao A, Nakamura M, Ueno S, Tanabe H, et al. Localization of a gene for benign adult familial myoclonic epilepsy to chromosome 8q23.3-q24.1. Am J Hum Genet. 1999;65:745–51.
doi: 10.1086/302535
Henden L, Freytag S, Afawi Z, Baldassari S, Berkovic SF, Bisulli F, et al. Identity by descent fine mapping of familial adult myoclonus epilepsy (FAME) to 2p11.2-2q11.2. Hum Genet. 2016;135:1117–25.
doi: 10.1007/s00439-016-1700-8
Depienne C, Magnin E, Bouteiller D, Stevanin G, Saint-Martin C, Vidailhet M, et al. Familial cortical myoclonic tremor with epilepsy: the third locus (FCMTE3) maps to 5p. Neurology. 2010;74:2000–3.
doi: 10.1212/WNL.0b013e3181e396a8
Yeetong P, Ausavarat S, Bhidayasiri R, Piravej K, Pasutharnchat N, Desudchit T, et al. A newly identified locus for benign adult familial myoclonic epilepsy on chromosome 3q26.32-3q28. Eur J Hum Genet. 2013;21:225–8.
doi: 10.1038/ejhg.2012.133
Ishiura H, Doi K, Mitsui J, Yoshimura J, Matsukawa MK, Fujiyama A, et al. Expansions of intronic TTTCA and TTTTA repeats in benign adult familial myoclonic epilepsy. Nat Genet. 2018;50:581–90.
doi: 10.1038/s41588-018-0067-2
Cen Z, Jiang Z, Chen Y, Zheng X, Xie F, Yang X, et al. Intronic pentanucleotide TTTCA repeat insertion in the SAMD12 gene causes familial cortical myoclonic tremor with epilepsy type 1. Brain. 2018;141:2280–8.
doi: 10.1093/brain/awy160
Zeng S, Zhang MY, Wang XJ, Hu ZM, Li JC, Li N, et al. Long-read sequencing identified intronic repeat expansions in SAMD12 from Chinese pedigrees affected with familial cortical myoclonic tremor with epilepsy. J Med Genet. 2019;56:265–70.
doi: 10.1136/jmedgenet-2018-105484
Lei XX, Liu Q, Lu Q, Huang Y, Zhou XQ, Sun HY, et al. TTTCA repeat expansion causes familial cortical myoclonic tremor with epilepsy. Eur J Neurol. 2019;26:513–8.
doi: 10.1111/ene.13848
Tankard RM, Bennett MF, Degorski P, Delatycki MB, Lockhart PJ, Bahlo M. Detecting expansions of tandem repeats in cohorts sequenced with short-read sequencing data. Am J Hum Genet. 2018;103:858–73.
doi: 10.1016/j.ajhg.2018.10.015
Dolzhenko E, van Vugt J, Shaw RJ, Bekritsky MA, van Blitterswijk M, Narzisi G, et al. Detection of long repeat expansions from PCR-free whole-genome sequence data. Genome Res. 2017;27:1895–903.
doi: 10.1101/gr.225672.117
Tang H, Kirkness EF, Lippert C, Biggs WH, Fabani M, Guzman E, et al. Profiling of short-tandem-repeat disease alleles in 12,632 human whole genomes. Am J Hum Genet. 2017;101:700–15.
doi: 10.1016/j.ajhg.2017.09.013
Dashnow H, Lek M, Phipson B, Halman A, Sadedin S, Lonsdale A, et al. STRetch: detecting and discovering pathogenic short tandem repeat expansions. Genome Biol. 2018;19:121.
doi: 10.1186/s13059-018-1505-2
Mousavi N, Shleizer-Burko S, Yanicky R, Gymrek M. Profiling the genome-wide landscape of tandem repeat expansions. Nucleic Acids Res. 2019;47:e90.
doi: 10.1093/nar/gkz501
Bahlo M, Bennett MF, Degorski P, Tankard RM, Delatycki MB, Lockhart PJ. Recent advances in the detection of repeat expansions with short-read next-generation sequencing. F1000 Res. 2018;7:736.
doi: 10.12688/f1000research.13980.1
Gandolfo LC, Bahlo M, Speed TP. Dating rare mutations from small samples with dense marker data. Genetics. 2014;197:1315–27.
doi: 10.1534/genetics.114.164616
Robinson JT, Thorvaldsdottir H, Winckler W, Guttman M, Lander ES, Getz G, et al. Integrative genomics viewer. Nat Biotechnol. 2011;29:24–6.
doi: 10.1038/nbt.1754
Rafehi H, Szmulewicz DJ, Bennett MF, Sobreira NLM, Pope K, Smith KR, et al. Bioinformatics-based identification of expanded repeats: a non-reference intronic pentamer expansion in RFC1 causes CANVAS. Am J Hum Genet. 2019;105:151–65.
doi: 10.1016/j.ajhg.2019.05.016
Sharma CM, Nath K, Kumawat BL, Khandelwal D. Autosomal dominant cortical tremor, myoclonus, and epilepsy (ADCME): probable first family from India. Ann Indian Acad Neurol. 2014;17:433–6.
doi: 10.4103/0972-2327.144025
Mahadevan R, Viswanathan N, Shanmugam G, Sankaralingam S, Essaki B, Chelladurai RP. Autosomal dominant cortical tremor, myoclonus, and epilepsy (ADCME) in a unique south Indian community. Epilepsia. 2016;57:e56–9.
doi: 10.1111/epi.13303

Auteurs

Mark F Bennett (MF)

Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3052, Australia.
Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.

Karen L Oliver (KL)

Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.

Brigid M Regan (BM)

Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.

Susannah T Bellows (ST)

Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.

Amy L Schneider (AL)

Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.

Haloom Rafehi (H)

Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.
Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3052, Australia.
Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.

Neblina Sikta (N)

Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia.

Douglas E Crompton (DE)

Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.
Neurology Department, Northern Health, Melbourne, VIC, 3076, Australia.

Matthew Coleman (M)

Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.

Michael S Hildebrand (MS)

Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.
Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, 3052, Australia.

Mark A Corbett (MA)

Robinson Research Institute & Adelaide Medical School, The University of Adelaide, Adelaide, SA, 5005, Australia.

Thessa Kroes (T)

Robinson Research Institute & Adelaide Medical School, The University of Adelaide, Adelaide, SA, 5005, Australia.

Jozef Gecz (J)

Robinson Research Institute & Adelaide Medical School, The University of Adelaide, Adelaide, SA, 5005, Australia.
South Australian Health and Medical Research Institute, Adelaide, SA, 5000, Australia.

Ingrid E Scheffer (IE)

Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.
Murdoch Children's Research Institute, Royal Children's Hospital, Parkville, VIC, 3052, Australia.
Department of Paediatrics, The University of Melbourne, Royal Children's Hospital, Parkville, VIC, 3052, Australia.
The Florey Institute, Parkville, VIC, 3052, Australia.

Samuel F Berkovic (SF)

Epilepsy Research Centre, Department of Medicine, The University of Melbourne, Austin Health, Heidelberg, VIC, 3084, Australia.

Melanie Bahlo (M)

Population Health and Immunity Division, The Walter and Eliza Hall Institute of Medical Research, Parkville, VIC, 3052, Australia. bahlo@wehi.edu.au.
Department of Medical Biology, The University of Melbourne, Parkville, VIC, 3052, Australia. bahlo@wehi.edu.au.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH